Helen McShane

Helen McShane in the video ''Exposed'' Helen Irene McShane is a British infectious disease physician and a professor of vaccinology, in the Jenner Institute at the University of Oxford, where she has led the tuberculosis vaccine research group since 2001. She is senior research fellow at Harris Manchester College, Oxford. Provided by Wikipedia
Showing 1 - 20 results of 58 for search 'Helen McShane', query time: 0.07s Refine Results
  1. 1
    Current approaches toward identifying a correlate of immune protection from tuberculosis

    Current approaches toward identifying a correlate of immune protection from tuberculosis by Iman Satti, Helen McShane

    Published 2019-01-01
    Get full text
    Article
  2. 2
    Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?

    Tuberculosis vaccines in the era of Covid-19 – what is taking us so long? by Hazel M. Dockrell, Helen McShane

    Published 2022-05-01
    Get full text
    Article
  3. 3
    Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges

    Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges by Hazel Morrison, Susan Jackson, Helen McShane

    Published 2023-05-01
    Get full text
    Article
  4. 4
    Rapid research response to the COVID-19 pandemic: perspectives from a National Institute for Health Biomedical Research Centre

    Rapid research response to the COVID-19 pandemic: perspectives from a National Institute for Health Biomedical Research Centre by Lorna R. Henderson, Helen McShane, Vasiliki Kiparoglou

    Published 2022-02-01
    Get full text
    Article
  5. 5
    Development and application of the direct mycobacterial growth inhibition assay: a systematic review

    Development and application of the direct mycobacterial growth inhibition assay: a systematic review by Hannah Painter, Eli Harriss, Helen A. Fletcher, Helen McShane, Rachel Tanner

    Published 2024-02-01
    Get full text
    Article
  6. 6
    A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge

    A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge by Elena Stylianou, Nawamin Pinpathomrat, Oliver Sampson, Alexandre Richard, Marcellus Korompis, Helen McShane

    Published 2023-10-01
    Get full text
    Article
  7. 7
    Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.

    Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy. by Angela M Minassian, Edward O Ronan, Hazel Poyntz, Adrian V S Hill, Helen McShane

    Published 2011-01-01
    Get full text
    Article
  8. 8
    Dual neonate vaccine platform against HIV-1 and M. tuberculosis.

    Dual neonate vaccine platform against HIV-1 and M. tuberculosis. by Richard Hopkins, Anne Bridgeman, Joan Joseph, Sarah C Gilbert, Helen McShane, Tomáš Hanke

    Published 2011-01-01
    Get full text
    Article
  9. 9
    A large National Institute for Health Research (NIHR) Biomedical Research Centre facilitates impactful cross-disciplinary and collaborative translational research publications and research collaboration networks: a bibliometric evaluation study

    A large National Institute for Health Research (NIHR) Biomedical Research Centre facilitates impactful cross-disciplinary and collaborative translational research publications and... by Vasiliki Kiparoglou, Laurence A. Brown, Helen McShane, Keith M. Channon, Syed Ghulam Sarwar Shah

    Published 2021-11-01
    Get full text
    Article
  10. 10
    Lessons from the pandemic on the value of research infrastructure

    Lessons from the pandemic on the value of research infrastructure by Laurence S. J. Roope, Paolo Candio, Vasiliki Kiparoglou, Helen McShane, Raymond Duch, Philip M. Clarke

    Published 2021-04-01
    Get full text
    Article
  11. 11
    “It seems impossible that it’s been made so quickly”: a qualitative investigation of concerns about the speed of COVID-19 vaccine development and how these may be overcome

    “It seems impossible that it’s been made so quickly”: a qualitative investigation of concerns about the speed of COVID-19 vaccine development and how these may be overcome by Poppy Brown, Felicity Waite, Michael Larkin, Sinéad Lambe, Helen McShane, Andrew J. Pollard, Daniel Freeman

    Published 2022-01-01
    Get full text
    Article
  12. 12
    Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.

    Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection. by Gareth Betts, Hazel Poyntz, Elena Stylianou, Arturo Reyes-Sandoval, Matthew Cottingham, Adrian Hill, Helen McShane

    Published 2012-01-01
    Get full text
    Article
  13. 13
    Markers of achievement for assessing and monitoring gender equity in a UK National Institute for Health Research Biomedical Research Centre: A two-factor model.

    Markers of achievement for assessing and monitoring gender equity in a UK National Institute for Health Research Biomedical Research Centre: A two-factor model. by Lorna R Henderson, Syed Ghulam Sarwar Shah, Pavel V Ovseiko, Rinita Dam, Alastair M Buchan, Helen McShane, Vasiliki Kiparoglou

    Published 2020-01-01
    Get full text
    Article
  14. 14
    Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.

    Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses. by Anna M Checkley, David H Wyllie, Thomas J Scriba, Tanya Golubchik, Adrian V S Hill, Willem A Hanekom, Helen McShane

    Published 2011-01-01
    Get full text
    Article
  15. 15
    The Humoral Immune Response to BCG Vaccination

    The Humoral Immune Response to BCG Vaccination by Rachel Tanner, Bernardo Villarreal-Ramos, Bernardo Villarreal-Ramos, H. Martin Vordermeier, H. Martin Vordermeier, H. Martin Vordermeier, Helen McShane

    Published 2019-06-01
    Get full text
    Article
  16. 16
    The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life.

    The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life. by Sarah Burl, Uche J Adetifa, Momodou Cox, Ebrima Touray, Hilton Whittle, Helen McShane, Sarah L Rowland-Jones, Katie L Flanagan

    Published 2010-08-01
    Get full text
    Article
  17. 17
    Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.

    Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants. by Matthew K O'Shea, Thomas E Fletcher, Nicholas J Beeching, Martin Dedicoat, David Spence, Helen McShane, Adam F Cunningham, Duncan Wilson

    Published 2014-01-01
    Get full text
    Article
  18. 18
    Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.

    Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A. by Kathryn T. Whelan, Ansar A. Pathan, Clare R. Sander, Helen A. Fletcher, Ian Poulton, Nicola C. Alder, Adrian V. S. Hill, Helen McShane

    Published 2011-01-01
    Get full text
    Article
  19. 19
    Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials.

    Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials. by Steven G Smith, Stephanie A Harris, Iman Satti, Donna Bryan, K Barry Walker, Hazel M Dockrell, Helen McShane, Mei Mei Ho

    Published 2017-01-01
    Get full text
    Article
  20. 20
    Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis.

    Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. by Steven G Smith, Simone A Joosten, Virginie Verscheure, Ansar A Pathan, Helen McShane, Tom H M Ottenhoff, Hazel M Dockrell, Françoise Mascart

    Published 2009-11-01
    Get full text
    Article

Search Tools: